Reduced quantity and function of pneumococcal antibodies are associated with exacerbations of COPD in SPIROMICS
Authors:
- 6 April 2023
- journal article
- research article
- Published by Elsevier in Clinical Immunology
- Vol. 250, 109324
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Heart Lung and Blood Institute
- National Center for Advancing Translational Sciences
- Institute for Clinical and Translational Research, University of Maryland, Baltimore (UL1 TR001079)
This publication has 37 references indexed in Scilit:
- Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS): Table 1Thorax, 2013
- Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseBMC Medicine, 2013
- Some Pneumococcal Serotypes Are More Frequently Associated with Relapses of Acute Exacerbations in COPD PatientsPLOS ONE, 2013
- Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & ImmunologyJournal of Allergy and Clinical Immunology, 2012
- Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortalityThorax, 2012
- Azithromycin for Prevention of Exacerbations of COPDNew England Journal of Medicine, 2011
- Serotypes and genotypes of Streptococcus pneumoniae causing pneumonia and acute exacerbations in patients with chronic obstructive pulmonary diseaseJournal of Antimicrobial Chemotherapy, 2010
- Superior Immune Response to Protein-Conjugate versus Free Pneumococcal Polysaccharide Vaccine in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Immune Response in Infants to the Heptavalent Pneumococcal Conjugate Vaccine against Vaccine-Related Serotypes 6A and 19AClinical and Vaccine Immunology, 2009
- Development and Validation of a Fourfold Multiplexed Opsonization Assay (MOPA4) for Pneumococcal AntibodiesClinical and Vaccine Immunology, 2006